Clinical Trials Browser

Phase 2 × Interventional × Intranasal Dexmedetomidine Breast Cancer Local Anaesthesia × Clear all

NCT02675049 2016-03-01

Efficacy and Optimal Dose Selection of Intranasal Dexmedetomidine During Breast Lumpectomy Under Local Anaesthesia

Phase 2 Completed

Intranasal Dexmedetomidine Breast Cancer Local Anaesthesia